Abstract
Age and diabetes related slow-healing or chronic wounds may result in morbidity and mortality through persistent biofilms infections and prolonged inflammatory phase. Nano-materials [metal/metal oxide NPs (39%), lipid vehicles (21%), polymer NPs (19%), ceramic nanoparticles (NPs) (14%), and carbon nanomaterials (NMs) (7%)] can be introduced as a possible next-generation therapy because of either their intrinsic wound healing activity or via carrying bioactive compounds including, antibiotics, antioxidants, growth factor or stem cell. The nanomaterials have been shown to implicate in all four stages of wound healing including hemostasis (polymer NPs, ceramic NPs, nanoceria-6.1%), inflammation (liposome/vesicles/solid lipid NPs/polymer NPs/ceramic NPs/silver NPs/gold NPs/nanoceria/fullerenes/carbon-based NPs-32.7%), proliferation (vesicles/liposome/solid lipid NPs/gold NPs/silver NPs/iron oxide NPs/ceramic NPs/copper NPs/self-assembling elastin-like NPs/nanoceria/micelle/dendrimers/polymer NPs-57.1%), remodeling (iron oxide NPs/nanoceria-4.1%). Natural compounds from alkaloids, flavonoids, retinoids, volatile oil, terpenes, carotenoids, or polyphenolic compounds with proven antioxidant, anti-inflammatory, immunomodulatory, or antimicrobial characteristics are also well known for their potential to accelerate the wound healing process. In the current paper, we survey the potential and properties of nanomaterials and microbial compounds in improving the process of wound and scar healing. Finally, we review the potential biocompounds for incorporation to nano-material in perspective to designate more effective or multivalent wound healing natural or nano-based drugs.
Introduction
Wounding disrupts the typical structure and function of the tissues and causes hemorrhage, vessel contraction via blood coagulation, activation of complement, and inflammation (Robson et al., 2001). Chronic, hard-to-heal wounds lead to a high rate of morbidity and mortality (Natarajan et al., 2000), and due to their considerable prevalence in the aged population, wound morbidity will have an immense social and economic impact in the future (Natarajan et al., 2000; Robson et al., 2001). This paper is a survey on the potential and properties of nanomaterials and microbial compounds in improving the process of wound and scar healing. The potential of biocompounds for incorporation to nano-material in perspective to the designation of more effective or multivalent wound healing natural or nano-based drugs is overviewed. In addition, the concerns on toxicity, aggregation and disintegration of the nanomaterial are also discussed in this review. According to the records on wound healing activity of nano and microbial-based substances, it prospects that some of the discussed substances in this review can be considered as future drug candidates.
Types of Wounds
The severity of the wound can be varied from a slight fracture in the skin, which is confined to the epithelial layer (closed wounds) or can be extended into the subcutaneous tissue (open wounds). Wounds may also result from physico-chemical damages or pathological processes of a disease like diabetes (). Immediately after the injury, the complicated process of healing begins, which is involved of several steps including hemorrhage, coagulation, acute inflammation, the proliferation of connective tissue and parenchyma cells, synthesis of extracellular matrix (ECM), and profound changes of ECM composition (Skover, 1991; Lawrence, 1998; Hart, 2002; Toy, 2005).
Acute wounds are spontaneously repaired during coordinated and highly regulated processes in approximate 5–10 days till the structure and function of injured tissues are restored (Lazarus et al., 1994; Robson et al., 2001). If healing processes is compromised or cannot be completed in the organized normal healing process, the postponed wound repairing or hard to heal chronic wound may occur owing to extension or discontinuation of each phase, which leads to chronic wounds (Szycher and Lee, 1992; Robson et al., 2001). Disturbance factors in non-healing wounds that interferes with one or more wound healing phases include infection, exudate, hypoxia in tissue, necrosis, and high amount of inflammatory cytokines. The structure and function of injured tissue cannot be revived, and such wounds frequently relapse. Because of a postponed, incomplete, or uncoordinated healing process, pathologic inflammation occurs in these non-healing wounds (; Vanwijck, 2001). Based on the contamination level, wounds can be divided into three types of aseptic, contaminated, and septic wounds (Komarčević, 2000; Vanwijck, 2001; Strecker-McGraw et al., 2007).
SKIN Wound Healing Process
Healing of wounds in the skin is a complex, evolutionarily conserved, significantly coordinated, and the precisely programmed event of healing the impaired tissue to restores its lost integrity. It necessitates a sequence of physiological and biochemical phenomena in four sequential, integrated, and sometimes overlapping phases, including hemostasis, inflammation, proliferation, and remodeling (Gosain and DiPietro, 2004). To have an optimal healing process, several critical events should have occurred during these four phases, including quick hemostasis; appropriate inflammation; differentiation, proliferation, and migration of mesenchymal cells to the wound site; proper angiogenesis; immediate re-epithelialization; and synthesis, cross-linking, and alignment of collagen to provide strength to the healing tissue. Keratinocytes, fibroblasts, immune, endothelial, and progenitor cells are some of the cells involved in the above phases. The interaction of these cells with each other and ECM are tightly controlled by some bioactive molecules and mediators such as the interleukin family, multiple growth factors, chemokines, and cytokines specified for every phase.
Hemostatic Events
The tissue injury leads to the release of thromboxane A2 and prostaglandin 2-alpha in the site of injury and vasoconstriction, which limits the bleeding, activates coagulation, and maintenance of vessel integrity (Sinno and Prakash, 2013). In the following several molecular events including, platelet activation, adhesion, aggregation, and clot formation, proceed by the activated complement cascades. Activated platelets by secreting several chemokines, including histamine, epidermal growth factor (EGF), fibrinogen, fibronectin, serotonin, von Willebrand factor, and platelet-derived growth factor (PDGF) along with thrombocytes are involved in the formation of the clot and stabilization of the wound (Heldin and Westermark, 1988). The generated fibrin network reestablishes homeostasis and forms a barrier against the microbial cells and organizes the critical temporary matrix for cell migration in consequent healing phases. The clot and surrounding wound tissues liberate pro-inflammatory cytokines and growth factors including, transforming growth factor (TGF)-β, PDGF, fibroblast growth factor (FGF), and EGF. Macrophages and fibroblasts are attracted and activated by the action of platelets to the wound site (Gosain and DiPietro, 2004; Janis and Attinger, 2006; ).
Inflammation
The activated complement cascade, platelet degranulation, and bacterial products lead to capillary vasodilatation and local release of histamine at the end of the hemostasis phase. This attracts the migration of inflammatory cells including neutrophils, macrophages, lymphocytes, and skin gamma-delta T-cells to the wound. Activated neutrophils by pro-inflammatory cytokines, such as IL-1β, tumor necrosis factor-alpha (TNF-α), and IFN-γ (interferon-gamma) enhance the expression of adhesion molecules, which facilitate their diapedesis and interaction with endothelial cells for transmission (Gonzalez et al., 2016). Neutrophils, as primary activated and recruited cells, scavenge different cell debris, degrade the invaders by producing proteases, lysosomal enzymes, and antimicrobial compounds such as reactive oxygen species (ROS), cationic peptides, and proteases (Gurtner et al., 2008). Activated macrophages release interleukins, TNF-α, TGF-β, PDGF, and vascular endothelial growth factors that recruit and activate additional leukocytes. They also stimulate fibroblasts and keratinocytes to initiate angiogenesis and formation of granulation tissue. These events lead to transmission into the proliferative phase and tissue regeneration (; ). Macrophages also facilitate the decontamination of the wound spot by degrading the apoptotic cells, phagocytosis, and secretion of multiple enzymes like collagenases. Endothelial cells are activated by a secreted factor of inflammatory cells, which lead to the production of PDGF, TGF beta, FGF, and vascular endothelial growth factor (VEGF) and provoke the generation of granulation tissue (Meszaros et al., 2000; Mosser and Edwards, 2008).
Proliferative Stage
The aim of the next stage of wound healing, the proliferative phase, is to diminish the trauma area of the tissue, which can be restored by the re-epithelialization, angiogenesis, granulation tissue formation, collagen deposition, and provisional matrix deposition processes. This phase begins within the first 48 h and can continue to 14 days (Li et al., 2007).
The angiogenesis as a collaborative process involves endothelial, and fibroblast cells, FGF, TGF-β, vascular endothelial growth factor, angiopoietin 1, angiotrofin, angiogenin, TNF-α, and thrombospondin and required oxygen, nutrients, and essential growth factors are provided through newly formed blood vessels (Folkman and D’Amore, 1996; Iruela-Arispe and Dvorak, 1997; Risau, 1997; Gurtner et al., 2008). Further angiogenesis and fibroplasia can be stimulated via released growth factors by macrophages (Sinno and Prakash, 2013). In the following, collagen, glycosaminoglycans, and proteoglycans as significant components of the ECM, including are produced (Gosain and DiPietro, 2004; ).
Remodeling
At the end of proliferation and synthesis of ECM, wound repairing will enter the final phase, remodeling, that commence three weeks after injury and can last for years (). For this purpose and to maintain a normal level of vascular density, many newly formed capillaries in the previous phase are regressed (Gosain and DiPietro, 2004; ). One of the crucial properties of the remodeling phase is significant changes in ECM, including degradation of type III collagen, hyaluronic, fibronectin acid, and synthesis of type I collagen to consequently provide the maximum tensile strength (Mir et al., 2018). Physical contraction of the wound has been facilitated by contractile fibroblasts after forming a monolayer of keratinocytes on the wound surface (Gosain and DiPietro, 2004; ).
Involved Targets in the Wound Healing Process
The activity and function of immune cells, fibroblasts, keratinocytes, ECM, cytokines, growth factors, reactive oxygen species, and various inflammatory mediators involved in the wound healing process can be considered as targets for drug discovery designs (Tsala et al., 2013; desJardins-Park et al., 2018; Kiritsi and Nyström, 2018). The cellular activity begins in hemostasis as the first phase of wound healing. Thus, compounds enhancing the blood vessel integrity or activating platelets can reduce the duration of bleeding, thereby represent wound healing activities (Rodriguez-Merchan, 2012).
As mentioned previously, migration, differentiation, and proliferation of immune cells, epithelial cells, fibroblasts, vascular endothelial cells, and their functions are critical for proper wound repair. Their delayed or disrupted process led to chronic or non-healing wounds. The compounds which can induce or accelerate these vital steps can be further investigated as future potential wound-healing drugs. For instance, it has been shown that nifedipine and amlodipine, as a calcium channel blockers, increase the strength of skin tensile, enhance the wound contraction rate and also partially reverse the steroid-induced suppressed wound healing in rats by affecting the metabolism of cellular calcium, which regulates the keratinocytes differentiation, ECM and collagen production (). Further, due to the critical role of ECM in adhesion, migration, proliferation, and differentiation, any compounds which suppress the ECM degradation in disturbing conditions may be valuable as a lead compound with wound healing property. MMPs from the CCN family are also significant targets as they elicit other cell-specific responses using several mechanisms, including expression of growth factors, cytokines, MMPs, and ECM proteins. Therefore, compounds affecting MMP expression in some diseases with deregulated MMP expression may also show wound healing activity (Jun and Lau, 2011).
The elevated levels of generated ROS during inflammation by immune and fibroblast cells can inhibit the microbial pathogens and, in parallel, impose series of adverse impacts on preceding wound healing phases and lead to severe tissue damage and even neoplastic transformation. Therefore, compounds with radical scavenging effect can accelerate the healing process in delayed wound healing (). Finally, compounds with a stimulation effect on angiogenesis may also improve the function of skin regeneration (Figure 1) (Majewska and Gendsazewska-Darmach, 2011).
FIGURE 1
Current Wound Repair Regimes
Current therapeutic strategies leading to the acceleration of the wound healing process are depicted in Figure 2. Some of the current therapies include split-thickness autograft, autograft using donor keratinocytes, autograft using cultured epithelial cells or stem cells; wound dressings using chitosan, hyaluronic acid, collagen, and silicon, delivery of growth factors or platelet-rich plasma, and debridement. The privilege and constraints of these therapies are surveyed in Figure 2 (Han and Ceilley, 2017).
FIGURE 2
Wound Healing Using Microorganisms
Although various activities of microbial products have been investigated (Salimi et al., 2018a; Salimi et al., 2018b; Salimi et al., 2019), their wound healing activities are less explored compared to their plant equivalent. Until now, healing activity of whole probiotic cells on burning, gastrointestinal, non-healing wounds, and scars has been proven. Wound healing activities of these microorganisms are related to their cell wall fragments, exopolysaccharide, antimicrobial, and anti-inflammation compounds, which can induce exceptional responses of the immune system in the skin and vitalize barrier functions of the skin (Figure 3) (Lew and Liong, 2013; Lukic et al., 2017; Shirzad et al., 2018).
FIGURE 3
Probiotic bacteria such as lactobacilli and bifidobacteria improve the wound healing process in the GI tract by activating the epithelial cells, stimulating proliferation and/or migration of fibroblast, increasing the synthesis of collagen, and affecting innate immune components of the intestinal barrier (Lew and Liong, 2013; Lukic et al., 2017). It has been shown that Lactobacillus reuteri can accelerate the wound-healing process via the up-regulation of the neuropeptide hormone oxytocin (Poutahidis et al., 2013).
Some researchers have been reported the wound healing activities of probiotics using a variety of experimental models like acetic acid-induced ulcers, full-thickness wounds, a hairless mouse model of UVB stimulated skin photo-aging and intestinal anastomoses. This promotion of the wound healing process by probiotics is attributed to the induction of β-defensin (Schlee et al., 2008) and expression of TGF-β (Dharmani et al., 2013), vascular endothelial growth factor (Dharmani et al., 2013), EGF, EGF receptor activity (EGFR), insulin-like growth factor (IGF) (Fordjour et al., 2010; Wang et al., 2014) and hypoxia-inducible factor 2α (HIF-2α) (Zhao et al., 2015). Also, probiotic bacteria improve tight barrier function in primary human keratinocytes through increasing the expression of tight junction protein in these cells, e.g., Lb. rhamnosus GG and Bifidobacterium longum increased tight junction function through the expression of claudin 1, zonula occludens 1, and occludin in keratinocytes infected with Staphylococcus aureus (Karczewski et al., 2010; Yang et al., 2015).
Probiotic bacteria such as Lb. rhamnosus GG and Lb. reuteri also enhances the re-epithelialization through the induction of chemokines or augmented keratinocyte migration and cellular proliferation. For instance, Lb. rhamnosus GG enhances the expression of the chemokine CXCL2 and its receptor CXCR2 that stimulates keratinocyte proliferation and migration during the normal process of wound healing (Mohammedsaeed et al., 2015).
Probiotic bacteria, via competitive exclusion and production of antibacterial compounds, can reduce the adherence and growth of pathogen ones, respectively (Prince et al., 2012). Hence some probiotic bacteria can prevent infections in cutaneous wounds, e.g., a combination of LAB and yeasts in kefir improved wound healing by producing antimicrobial compounds (Huseini et al., 2012). Reuterin (3- hydroxypropionaldehyde) is a well-known antimicrobial compound generated by Lb. reuteri that is supposed to impose its effect by oxidization of thiol groups in the target pathogens. Notably, reuterin can remarkably inhibit the growth of pathogenic gut bacteria, without affecting beneficial microbiota. Reuterin also exhibits antimicrobial activity on Staphylococcus as a common pathogen of chronic wounds (Schaefer et al., 2010). Lb. reuteri and Lb. rhamnosus GG inhibit the growth of S. aureus in infected keratinocytes through suppressing the primary adhesion of this pathogen to keratinocytes. By enhancing phagocytosis, Lb. plantarum prevented wound colonization by P. aeruginosa S. aureus, and S. epidermidis in a burn mouse model (Prince et al., 2012; Mohammedsaeed et al., 2015). The mechanism of IL-8 level regulating and modulating the entry and activity of PMNs migrating from peripheral blood to the ulcer enables the Lb. plantarum to inhibit the colonization of the pathogen (Peral et al., 2010).
Probiotic bacteria also disrupt the pathogenic agents through interfering with quorum sensing of pathogens usually found in chronic wounds). Especially, Lb. plantarum was supposed to inhibit the synthesis of QS signaling molecules (acyl-homoserine- lactone) by P. aeruginosa, together with the decline of biofilm (Valdez et al., 2005). Also, some probiotic bacteria produce several other metabolites including, hyaluronic acid, sphingomyelinase, lipoteichoic acid, alginate, diacetyl, and acetic acid, to stimulate the wound healing (; Kogan et al., 2007). Hyaluronic acid acts as a matrix in mammalian to preserve the original structure of the epidermal layer against infections. Furthermore, hyaluronic acid affects the proliferation and differentiation of cells and immobilizes water in tissues (Weindl et al., 2004). Hyaluronic acid also accelerates the healing process via its antioxidant activity (Trabucchi et al., 2002). The considerable therapeutic activity of exogenous hyaluronic acid on wounds including, preserving moisture in wound sites, promoting migration of epithelial cells, regeneration, and remodeling processes, encourage its large scale production (). In this regard, microbial sources can be a suitable option for the production of hyaluronic acid. Additionally, microbial sources have lower undesired and interfering compounds such as proteins and nucleotides compared to animal sources. Streptococcus thermophiles, Streptococcus zooepidemicus, and Lactobacillus rhamnosus FTDC 8313, Lactobacillus gasseri FTDC 8131, and Pasteurella multocida are among known instance of hyaluronic acid-producing bacteria (Izawa et al., 2009; Liu et al., 2009; Lew et al., 2013). The recombinant hyaluronic acid has also been produced in genetic engineered Bacillus subtilis 168 and Lactococcus lactis LL-NAB and transformed Streptococcus thermophilus YIT2084 strains (Widner et al., 2005; ).
A family of ceramides and phosphorylcholine can be generated by the activity of sphingomyelinase from glucosylceramide and sphingomyelin precursors (Jensen et al., 2005). The action of this enzyme is critical for the skin barrier function (). Bacteria, yeast, and mammalian cells produce sphingomyelinase. Streptococcus thermophiles, lactobacillus, and bifidobacteria strains are microbial sources of sphingomyelinase. Since divalent metal ions can improve binding affinity between the sphingomyelinase and sphingomyelin, therefore, the production of sphingomyelinase from Streptococcus thermophiles can be enhanced via adding divalent metal ions into the growth culture (Di Marzio et al., 1999; Lew and Liong, 2012).
Lipoteichoic acid induces tolerances via protecting against the overproduction of proinflammatory cytokines. Lipoteichoic acid, through the induction of toll-like-receptor, stimulates skin defense against microbial threats, leading to a release of the antimicrobial peptides like β-defensins and cathelicidins. Lactobacillus plantarum, lactobacillus, and bifidobacterial strains are lipoteichoic acid-producing bacteria (Schauber and Gallo, 2008; Lew and Liong, 2012; Kim et al., 2013).
In addition to the mentioned compounds, bacteria such as Azotobacter vinelandii ATCC 9046 can accelerate wound healing by producing alginate with improved binding affinity compared to marine alginate (Fischer et al., 2017). Further, it was shown that EPS derived lactic acid bacteria prevented ultraviolet-induced skin damage in hairless mice (Morifuji et al., 2017).
Nanomaterial and Wound Healing
Many nano-based products have been introduced for their specific wound healing activity, and some of them are currently under clinical investigation. Nanomaterials with tissue regeneration ability have been developed with different structures including, nanoparticles, nanospheres, nanocapsules, nanoemulsions, nanocarriers, and nanocolloids (Naskar and Kim, 2020). The nanomaterials can be applied in two distinct principles. First, they can possess intrinsic wound healing properties including carbon-based nanoparticles (Table 1), metallic/metal oxide nanomaterials like silver, gold, copper, titanium, terbium, and zinc, nonmetallic nanomaterials such as graphene, and metalloid-based nanoparticles like silica (Table 2). Second, they can be used as carriers including, nanospheres, nanocapsules, nanoemulsions, nanocarriers, and nanocolloids, liposomes, micelles, vesicles, solid lipid nanoparticles, and nanofibers for therapeutic agents like various growth factors, cytokines, thrombin, nitric oxide (NO), antibiotics, angiogenic factors, opioids or even stem cells that can accelerate healing of chronic wounds (Figure 4) (Table 3) (Tran et al., 2009; Tocco et al., 2012; Nam et al., 2015; Urie et al., 2018).
TABLE 1
| Compound category | Bioactivities | Compound name | Phase | Mechanisms | Models | Ref |
|---|---|---|---|---|---|---|
| Fullerenes carbon-based NPs | Antioxidant, anti-inflammatory activities | Liposomal formulated amphiphilic fullerenes | Inflammatory and proliferative phases | Accelerate the wound closure | Oris™ cell migration assay | Zhou et al., (2010) |
| Graphene, carbon-based NPs | Antibacterial activity | Nanofibers containing grapheme. Hybrid nanosheets of g-C3N4-Zn2+graphene oxide | Proliferative phase. Inflammatory and proliferative phases | Skin recovery and wound disappearance. Upregulating gene expressions of MMP-2, type I collagen, type III g-C3N4 collagen, and interleukin β in fibroblasts | Wound-healing in mouse and rabbit. Circular wounds with S. aureus infection in rat models | Lu et al., (2012); Mihai et al., (2018) |
| Dendrimers | Antibacterial, antifungal activities | Arginine-grafted cationic dendrimer | Proliferative phase | Provides rapid proliferation of basal cells and collagen deposition | Wound healing in diabetic and normal mice | Winnicka et al., (2011); Kwon et al., (2012); Gholami et al., (2017) |
| Self-assembling elastin-like NPs | Proliferative activity | Elastin-like peptides | Proliferation phase | Increase fibroblast proliferation, improve re-epithelialization and granulation | Wound healing model in diabetic mice model | Koria et al., (2011) |
Intrinsic wound healing activities of carbon-based nano-material.
TABLE 2
| Nano-material category | Bioactivities | Compound name | Phase | Mechanisms | Models | Reference |
|---|---|---|---|---|---|---|
| Sliver NPs | Anti-inflammatory, antimicrobial and antioxidant activities | Silver nanoparticles modified with chondroitin sulfate and acharan sulfate | Inflammatory and proliferative phases | Prevents wound infections, accelerates collagen deposition and collagen formation in the wound area | In vivo model of wound healing using old male ICR. Mice | Im et al., (2013) |
| Silver nanoparticles coated with an oligonucleotide ([5′-HS-(CH2)6-TAATGCTGAAGG-3]) | Inflammatory and proliferative phases | Induce collagen deposition, improve congestion, infiltration of inflammatory cell and proliferation of fibroblast | In vivo model of full-thickness skin in adult male Balb/c mice | Fukui et al., (2012) | ||
| Silver nanoparticle impregnated Chitosan-PEG hydrogel | Inflammatory phase | Improved antimicrobial and antioxidant properties | Diabetes induced rabbits | Masood et al., (2019) | ||
| Gold (Au) NPs | Antioxidant, anti-inflammatory activities | Au NPs conjugated with epigallocatechin gallate (EGCG) and alpha lipoic acid | Inflammatory, proliferative and angiogenesis phases | Increase proliferation and migration of Hs68 and HaCaT. Increase expression of growth factor angiopoietin-1 protein and in vascular endothelial cell and increase Cu/Zn SODs in the wound area | In vivo model of cutaneous wound in diabetic mice | Leu et al., (2012) |
| Gold nanoparticles | Stimulate angiogenesis, vascularization, trigger inflammatory response and enhance epithelialization through collagen deposition | In vivo model of wound healing in a mouse | Lau et al., (2017) | |||
| Negatively-charged-surface AuNPs | Decrease pro-inflammatory cytokines including IL-6, IL-12, and TNF-α | In vitro model of wound scratch | Pivodová et al., (2015) | |||
| AuNPs | Promote new blood vessel formation and induce migration of HUVECs cells into the wound area | In vivo model of chick embryo | ||||
| Phytochemically stabilized gold nanoparticle | Increase expression of collagen, VEGF, angiopoietin 1, and angiopoietin 2, enhance the activity of superoxide dismutases and decrease expression of (MMP)-1 and TGF-β | In vivo model of wound healing in Sprague Dawley rats | Kim et al., (2015) | |||
| Nanoceria | Antioxidant and antimicrobial activities | Water-soluble cerium oxide nanoparticles (nanoceria) | Proliferation and inflammatory phases | Accelerate proliferation and migration of fibroblasts or keratinocytes, reduce oxidative damage to cellular membranes and proteins | In vitro assay using human keratinocyte cells and full-thickness skin wounds as in vivo assay | |
| Nanoceria-microRNA-146a conjugate | Reduces oxidative stress and regulates macrophage polarization | In vivo model of wound healing in diabetic mice | Xu et al., (2016) | |||
| Cerium oxide nanoparticle functionalized PCL-Gelatin electrospun fibers | Induce complete re-epithelialization | Cell proliferation assay | Rather et al., (2018) | |||
| Cerium oxide nanoparticles | Inflammation, angiogenesis and proliferative phases | Induce hydroxyproline and collagen production that increase wound tensile strength. Induce angiogenesis and infiltration of inflammatory cells into the wound area | In vivo model of wound healing using mice | ; ; ; | ||
| Cerium oxide nanoparticles | Increase wound tensile strength through high production of collagen and hydroxyproline | In vivo wound healing model of i8-week-old female. Sprague–Dawley rats | Loomba and Scarabelli, (2013) | |||
| Cerium oxide nanoparticles | Prevent infection, enhance proliferation and migration of keratinocytes and fibroblasts | In vitro model of human keratinocyte cells and murine, dermal fibroblasts. In vivo model of 3–4-month-old male C57BL/6 mice | Ziv-Polat et al., (2010); Meddahi-Pellé et al., (2014) | |||
| Cerium oxide nanoparticles | Modulates intracellular oxygen level and activates HIF-1a | In vitro model using cell culture of HUVECs | Trickler et al., (2012) | |||
| Titanium nanoparticles | Antimicrobial and anticancer activities, UV-protection and mosquitocidal properties | Titanium dioxide (TiO2) nanoparticles. TiO2 nanoparticles | Proliferation and inflammation phases | Induce proliferation of fibroblast. Reduce the wound area by forming an adherent crust | Skin wound mouse model. In vivo wound healing in a rat burn model | Gao et al., (2017); Seisenbaeva et al., (2017) |
| Zinc | Antimicrobial, anti-inflammatory, and antioxidant activities | Zinc oxide (ZnO) nanoparticles | All phases | Induce proliferation of fibroblast | Skin wound mouse model | Gao et al., (2017) |
| Prolierative activity | β-chitin hydrogel/nano zinc oxide composite | Shows the blood clotting effect, platelet activation, promote migration of keratinocytes and antibacterial activities | In vivo evaluation in Sprague–Dawley rats. In vivo and in vitro evaluation of antimicrobial activities | Kumar et al., (2013) | ||
| ZnO nanoflowers | Induce proliferation and migration of endothelial cells that lead to the formation of new blood vessels | In vitro egg yolk angiogenesis and endothelial cell migration assay | ||||
| ZnO nanoparticles in polycaprolactone matrix | Enhance cell proliferation and induce the formation of blood vessels | In vivo vascularization. Assay. In vitro fibroblast proliferation | ||||
| ZnO nanoparticles in sodium alginate and gum acacia hydrogels | Promote fibroblast proliferation | In vitro wound healing assay on sheep fibroblast cells | Raguvaran et al., (2017) | |||
| ZnO nanoparticles | In vitro wound healing assay on fibroblast cells (NIH3T3) | Kaushik et al., (2019) |
Intrinsic wound healing activities of metal-based nano-products.
FIGURE 4
TABLE 3
| Nano-material category | Carrier name | Targeting phase | Mechanisms | Model of the investigation | Reference |
|---|---|---|---|---|---|
| Nitric oxide carrying nanomaterials | Nitrite containing hydrogel/glass composites. NO-releasing nanoparticles | All phases | NO remains trapped within its dry matrix until exposure to moisture. Exert antimicrobial activity and accelerate closure of the wound | Murine wound model | Friedman et al., (2008); Martinez et al., (2009) |
| Nanomaterials loaded by growth factor | Embedded hyaluronan-based porous nanoparticles with PDGF | Hemostasis phases | Accelerates treatment of skin ulcers | In vivo model of full-thickness wounds in wistar rats | Zavan et al., (2009) |
| Nanoparticles loaded by opioids | Nanoparticles loaded by opioids | Proliferation and remodeling phases | Increase penetration of opioids in the skin while diminishing their release rate, stimulate cell migration and closure of wounds | In vitro model of keratinocyte-derived cell line (HaCaT) | |
| Nanoparticles loaded by antibiotics | Carboxymethyl chitosan-based nanoparticles. Antibiotics incorporated polyacrylate nanoparticles | Hemostasis and inflammation phases | Maintain stable concentration of antibiotic during 24 h, increase the solubility of antibiotics | In vitro release of vancomycin and its measurement using HPLC | Hachicha et al., (2006); Turos et al., (2007); |
| Iron oxide NPs | Thrombin-conjugated γ-Fe2O3 nanoparticles | Hemostasis and inflammation phases | Enhance the bioavailability of thrombin and accelerates the healing of incisional wounds by a relative improvement of skin tensile strength | In vivo model of dorsal skin wound repair | Ziv-Polat et al., (2010) |
| Micelles | Ionic polymeric micelles based on chitosan and fatty acids | Proliferation phase | Induce cell proliferation | In vitro model using human dermal fibroblasts | |
| Liposome | Liposomes containing madecassoside (MA) | Inflammation phases | Enhance MA delivery toward wound healing | In vivo model of burn wound healing | Li et al., (2016) |
| Liposome entrapment of bacteriophages | Inflammatory phase | Lead to better phage persistence at the wound site | In vivo model of wound healing in diabetic mouse with MRSA infection | ||
| Basic FGF -encapsulated liposomes | Proliferative phase | Induce fast collagen generation and dermal cell proliferation | In vivo model of deep second-degree burn wound model in rats | Xiang et al., (2011) | |
| Quercetin-loaded liposomes | Proliferative phase | Leads to better drug release in wound sites | In vitro characterization of entrapment efficiency, drug release, and mean particle size | Moretti et al., (2016) | |
| Submicroscopic. Liposomes gll-phl-chol-α-gal | Hemostasis phase | Activate the cascade of the compliment, increase concentrations of chemotactic factors in the wound site, activate secretion of prohealing cytokines | In vivo model of wound healing in diabetic mouse | Kwon et al., (2012) | |
| Vesicles | Phospholipid bilayer vesicles loaded by hemoglobin and coated with polyethylene glycol | Angiogenesis phase | Enhance the oxygenation of ischemic cutaneous wounds through capillary formation and expression of endothelial nitric oxide synthase | In vivo model of wound healing in diabetic mouse | Plock et al., (2009); Fukui et al., (2012) |
| Adenosine triphosphate (ATP)-vesicles | Inflammatory and proliferation phases | Provide an energy source for cell survival, enhance granulation and re-epithelialization, stimulate infiltration of neutrophils, lymphocytes, and macrophages | In vivo model of the wound in the rabbit’s diabetic model for both nonischemic and ischemic models | Wang et al., (2010) | |
| Solid lipid NPs (SLNPs) | Recombinant human EGF loaded SLNPs | Proliferative phase | Induce cell proliferation | In vitro cell culture model of using fibroblasts and keratinocytes | |
| Astragaloside IV enriched solid lipid nanoparticles incorporated in carbomer hydrogel | Improves migration and proliferation of keratinocytes and inhibits scar formation | In vitro culture of immortalized human fibroblast and keratinocyte in vivo model of rat full skin excision | |||
| Morphine loaded SLNPs | Accelerate reepithelialization and prolong morphine release | Human-based 3D-wound healing model | Küchler et al., (2010) | ||
| Essential oil loaded SLNPs | Enhance proliferation | In vitro model of fibroblasts cell culture. In vivo model of burn wound healing in rat | Saporito et al., (2018) | ||
| Nanofiber | Berberine loaded electrospun poly-(ε-caprolactone) nanofibrous membrane | Hemostasis, inflammation and proliferation phases | Promotes hemostasis to minimize wound bleeding, inhibits bacterial growth, absorbs bio-fluid, encourages the growth of cells | Skin fibroblast attachment assay, blood clotting test and platelet adhesion assay | |
| Silver nitrate solution treated composite nanofibrous mats consist of a mixture of chitosan, gelatin and shape memory polyurethane | Hemostasis phase | Induces premier hemostatic effect than that of gauze | Whole blood clotting test | Tan et al., (2015) | |
| Gelatin blended chitosan nanofiber mats | Hemostasis phase | Induce premier blood clotting efficiency than that of chitosan nanofibers | In vitro blood clotting test using rabbit blood | Gu et al., (2016) | |
| Sandwiched PLGA/PLA-b-PEG electrospun layer by layers of carboxymethyl chitosan sponge | Hemostasis phase | Imposes higher hemostasis in rats’ cecum and prevents the formation of abdominal adhesions | In vitro blood coagulation test. In vivo hemostatic capability | Xia et al., (2015) | |
| N-octyl-2-cyanoacrylate (OCA) ultrathin fibers | Hemostasis phase | Induce rapid hemostasis | In vitro and in vivo rapid hemostasis evaluation in pig liver incision | Jiang et al., (2014) | |
| Graft copolymer | (PCL-PVA-PEG) loaded with piroxicam | Not reported | Provides consistent and sustained drug release | In vitro drug release assay | Paaver et al., (2014) |
The nano-products with wound healing activity via carrying nitric oxide, growth factors, thrombin, nitric oxide, antibiotics, angiogenic factors, and opioids.
These carriers control the release rate of therapeutic agents and increase their solubility, prolong their effect in the specified location and reduce the number of required doses, ultimately decrease the risk of development of antibiotic-resistant microorganisms through stabilizing protein structure and their biological activity, protecting proteins from inactivation by proteolytic enzymes in the wound site and regulating the drug release and increase their half-life (Tran et al., 2009; Tocco et al., 2012; Nam et al., 2015; Urie et al., 2018).
Nevertheless, in some cases, the property of chronic wound environments like being the high proteolytic, low frequency of growth factor receptors, and signaling molecules has been limited their application. Also, gene encapsulation using electro-spun nano-fibrous meshes in preparing wound-dressing materials has shown promising results. Using this approach, the expression of a target gene involved in regeneration can be enhanced or reduced. Nanofibres also can support cell adhesion, proliferation, and differentiation and provide sufficient oxygen and water. This potential is attributed to their permeability and prevention of bacterial infections in the wound site by excluding bacterial penetration. Polymeric nanomaterials like chitosan, cellulose, gelatin, dendrimers in different forms including, hydrogels, membranes, films, sponges, and scaffolds due to their antimicrobial, re-epithelialization, immune modulation, superior permeability, and being non-toxic characteristics have been applied as wound dressings or as delivery vectors to treat wounds. They can guarantee a moist wound environment via taking up a considerable amount of liquid (Mihai et al., 2019). The following are some of the studies that revealed wound healing properties of nano-based materials.
Antibacterial characteristics and low toxicity of metal nanoparticles like silver, gold, and zinc make them ideal options for integration in wound dressings like nanocoatings (Mihai et al., 2018). Reduced toxicity of AgNPs can be related to their increased surface-to-volume ratio and controlled release, which leads to their efficacy in a lower concentration. Wound healing activity of AgNPs can be related to their role in modulating the release of the anti-inflammatory cytokine, promoting wound closure and contractility, inducing the differentiation of myofibroblasts from normal fibroblasts, stimulating epidermal re-epithelialization and finally inhibiting bacterial pathogen growth. Generated sulfuric bonds with either microbial cell membrane proteins or thiol groups of various enzymes result in apoptosis of microbial cells. Applying AgNPs along with different antimicrobial drugs like tetracycline can considerably reduce bacterial contamination in tissue layers in in vivo model, so it promotes the healing process (Mihai et al., 2019). The following are some of the studies that revealed wound healing of AgNPs.
Lu et al., synthesized sponge-like nanoAg/ZnO-loaded chitosan composite dressing through the lyophilization process and subsequent incorporation of Ag/ZnO nanocomposites in synthesized sponge structure. The synthesized composite dressing exhibited enhanced blood clotting and antibacterial activity, promoted wound healing, re-epithelialization, and collagen deposition and showed very low toxicity (Lu et al., 2017). Khatami et al., reported that green synthesized Ag, ZnO, and Ag/ZnO via Prosophis fracta and coffee showed significant antibacterial activity against Acinetobacter baumannii and Pseudomonas aeruginosa, which may have the potential to apply in treating diabetic or burn wounds (Khatami et al., 2018). Yu et al., developed a new silkworm cocoon-based wound film wound dressing and, via reducing the ability of silk sericin incorporated Ag nanoparticles in synthesized film. This film promoted the healing process of infected wounds in New Zealand White rabbits and the reconstruction of the intact and thickened epidermis in impaired wound tissue during 14 days (Yu et al., 2017). Alipour et al. showed wound healing properties of silver nanoparticles embedded in electrospun nanofibers containing polyvinylalcohol (PVA), polyvinylpyrrolidone (PVP), pectin (PEC), and Mafenide acetate (MF). They showed the incorporation of silver nanoparticles into PVA/PVP/PEC/MF matrix had a remarkable effect on wound healing in New Zealand white rabbits (). Zhou et al. synthesized ultrafine silver/silver chloride anchored on reduced graphene oxide with stability and bactericidal activity. In vivo analysis showed that this nanocatalyst could accelerate the regeneration of the epidermis. Therefore has the potential to repair burn wounds (Zhou et al., 2016).
AuNPs can impose their healing activity though antioxidant or bactericidal activity, including targeting the bacterial cell wall and their DNA (Nethi et al., 2019). Akturk et al. showed wound healing ability of nanocomposite collagen scaffolds incorporating gold nanoparticles (AuNPs). Incorporation of AuNPs into cross-linked scaffolds enhanced their stability against enzymatic degradation and increased the tensile strength. The collagen sponge AuX group suppressed the inflammation. Neovascularization was also significant in collagen sponge AuX (). Li et al. synthesized chitosan incorporated Au-Ag NPs as wound dressing (CS-Au-Ag). The release of silver ions was occurred faster, in the higher amount, and a more durable manner in CS-Au-Ag in comparison to CS-Ag. Also, CS-Au-Ag exhibited increased antibacterial activity and low cytotoxicity. According to their results, CS-Au-Ag broadly promoted wound healing compared to CS-Ag (Li et al., 2017). Wang and coworkers prepared chitosan (CS) film modified with arginine (Arg) and gold NPs (AuNPs). The modification of Arg and AuNPs improved the hydrophilicity, mechanical strength, and antibacterial properties of the film, which in turn provided an enhanced ideal environment for cell adhesion and proliferation. The CS-Arg/AuNP dressing accelerated wound closure, re-epithelialization, and collagen deposition (Wang et al., 2020).
It has been revealed that zinc oxide nanoparticles exhibited a considerable antimicrobial activity. They can induce perforations in the bacterial cell membraneand accelerate the migration of keratinocyte, and consequently, re-epithelialization. In Khorasani et al. study it has been shown that polyvinyl (alcohol)/chitosan/nano zinc oxide nanocomposite with no toxicity and antibacterial activity can treat the wounds sufficiently (Khorasani et al., 2019). Ahmed et al. synthesized nanofiber mats composed of a combination of chitosan, polyvinyl alcohol (PVA), and Zinc oxide (ZnO). The results showed that chitosan/PVA/ZnO nanofibrous membranes had a more inhibitory effect on E. coli, P. aeruginosa, B. subtilis, and S. aureus than chitosan/PVA nanofibrous membranes. Also, chitosan/PVA/ZnO nanofibrous membranes imposed more antioxidant potential and wound healing activity than chitosan/PVA nanofibrous mats ().
Copper, via promoting VEGF, upregulating expression of integrin, stabilizing extracellular matrix proteins, fibrinogen, and collagen formation imposes its role in the wound healing process. Tao et al., reported a composite hydrogel consists of methacrylate-modified gelatin (Gel-MA), and N,N-bis(acryloyl)-cystamine (BACA)-chelated Cu, which showed antimicrobial activity against Staphylococcus aureus and Escherichia coli. It also stimulated NIH-3T3 fibroblast proliferation and chronic wound healing process of the S. aureus-infected model (Tao et al., 2019).
Terbium hydroxide nanoparticles (TbNPs) also affected angiogenesis, viability, proliferation, and migration of endothelial cells. So they can accelerate wound healing (Nethi et al., 2019). In addition, silica has been used to generate more effective wound dressing materials to treat wounds. Since these nanoparticles with a positive charge are easily absorbed by the fibroblast cells, release silicic acid, and ultimately stimulate wound healing (Nethi et al., 2019). Nonmetallic inorganic nanoparticles like iodine nanoparticles showed significant inhibitory effects on bacterial growth and biofilm formation at very low concentrations and wound healing ability in in vivo model (Viswanathan et al., 2017).
Biocompounds Incorporated Into Nanomaterials for Wound Healing
Antibiotics are currently used to inhibit colonization and the growth of microbial pathogens in the wound site. However quick removement antimicrobial agents from the bloodstream and their degradation rate limit their efficiency. In this regard, local administration of antimicrobial agents including, Ciprofloxacin, silver sulfadiazine, tetracycline, gentamycin via antibiotics incorporated polymers is being applied. This approach provides a controlled release of antibiotics and can make an aseptic space at the wound site (Miguel et al., 2019; Fang et al., 2020). Liu and collaborators synthesized ciprofloxacin loaded electrospun hydrophobic poly (lactic-co-glycolic acid) (PLGA) fibrous mats modified with hydrophilic sodium alginate (ALG) microparticles. The results showed that ALG enhanced the ciprofloxacin release rate from the PLGA fibrous mats. Aso, ALG decreased the stiffness of PLGA fibrous mats to efficiently protect the wound site (Liu et al., 2018). Mahmoud and coworkers prepared norfloxacin-loaded scaffolds to treat wounds through mixing collagen and two different types of chitosan. It was observed that the tissue regeneration duration in the norfoloxacin-loaded collagen/chitosan scaffolds was faster than that of non-treated wounds in Albino rats. (Mahmoud and Salama, 2016). In another study, mesoporous silica MCM-41 was incorporated into carboxymethylcellulose hydrogel. Then Tetracycline and methylene blue were loaded to the prepared nanocomposite. This nanocomposite showed an improved in vitro water vapor, erosion, swelling, oxygen permeability, and antimicrobial activity (Namazi et al., 2016).
Various growth factors and cytokines including, platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor-β (TGF- β), and vascular endothelial growth factor (VEGF), control wound healing phases like modulation of the inflammatory response, angiogenesis remodeling, and the reepithelialization processes. Several drawbacks including, little stability, removement through exudation, limited taking up via the skin, side effects of their high concentration in the administrated sites has been limited their topical application. So synthesizing growth factor loaded polymers can be considered as a promising approach in the wound healing process (Miguel et al., 2019). Lord and coworkers prepared plasmid DNA encoding perlecan domain I and VEGF189 loaded chitosan scaffolds. These scaffolds improved dermal wound healing in normal and diabetic rats. (Lord et al., 2017). In another study, thiolated heparin, and diacrylated poly (ethylene glycol) was prepared and loaded with human epidermal growth factor. A sustained release profile of hEGF was observed. Applying this hydrogel sheet improved wound closure in comparison with the non-treated control group (Goh et al., 2016).
Vitamins, especially Vit-A, C, and E, can improve the wound healing process. Enhancing the population of macrophages and monocytes at the wound site, stimulating the collagen synthesis, and re-epithelialization can be achieved via Vit-A. Vit-E also via antioxidant and anti-inflammatory properties, and the ability to accelerate the angiogenesis can improve the wound healing. In this regard, Voss et al. synthesized vitamin C (VitC) and/or propolis (Prop) loaded cellulose-based films. These films can control the release of vitamin C and possess antimicrobial ability against Escherichia coli and Staphylococcus aureus. Treated diabetic mice with the Cel-PVA/VitC/Prop treatment showed accelerated wound healing (Voss et al., 2018).
The inflammatory and hemostasis phases usually occur simultaneously to coincide losses of blood and fluid and eliminate dead tissues and prevent microbial contamination. In inflammation, monocytes, macrophages, and neutrophils act as wound cleaners via eliminating all dead cells, degraded extracellular matrix, and bacteria from the wound site. They also produce growth factors that attract other cells like smooth muscle cells and fibroblasts and into the injured area. Although extended inflammatory processes, chronic inflammation, generates excessive inflammatory mediators, cytotoxic enzymes, and free radical species, which postpone the physiological healing mechanisms and harm the surrounding tissue. So, the anti-inflammatory compounds incorporated wound dressings are considered as a promising approach to treat wounds (Miguel et al., 2019). Morgado et al. synthesized ibuprofen-β-cyclodextrins loaded poly (vinyl alcohol)/chitosan. According to their results, β-cyclodextrins provided a controlled drug release from the hydrogels that is the main property for applying them in wound management. Moreover, these hydrogels accelerate skin healing (Morgado et al., 2017).
Finally, many bioactive compounds like plant or microbial extracts and essential oils (Miguel et al., 2019), curcumin (Karri et al., 2016; Zahiri et al., 2020), propolis (Voss et al., 2018), and superoxide dismutase (Zhang et al., 2018) have been incorporated into a wound dressing to improve the rate of the healing process. Active agents in extracts including, terpenoids, terpenes, and aromatic and aliphatic compounds via antimicrobial, anti-inflammation, and antioxidative activities, can accelerate various phases of wound healing. Wound dressing can enhance the efficiency, bioavailability, stability, and solubility of these compounds (Miguel et al., 2019).
Toxicity of NANO-BASED Material for Wound Healing
It has been reported that AuNPs increase the growth rate and differentiation of keratinocytes, which in higher doses can cause cell toxicity. Also, applying ZnONPs in high concentrations can lead to mitochondrial in dysfunction of keratinocytes, which causing the release of lactate dehydrogenase. They also may produce radical species and prevent expression and consequently, production of superoxide dismutase and glutathione peroxidase genes in keratinocytes. These events can result in oxidative stress of cell membranes and cell apoptosis. Also, ZnONPs may associate with carcinogenic transformations (Yang et al., 2009).
Future Perspective
According to the considerable number of reported wound healing activity of nano and microbial-based substances, it is evident that some of these substances can be considered as future drug candidates. Despite the wound healing activities of introduced compounds via nanotechnology and microbiology, their application has some limitations and risks. Mainly, the small size of nanomaterial can lead to increased interparticle friction and sticking or raised chemical reactivity due to their increased surface area, which can result in undesired reactions like unwanted entering into the blood-brain barrier, initiation of blood coagulation, production of reactive oxygen species (Zhou et al., 2017). Generated oxidative stress can lead to biomolecules and subsequent severe cell damage (Yang et al., 2009).
It has been shown that PAMAM’s initiate uncontrolled autophagic cell death (; Li et al., 2015). Because of their small size, they may have a highly increased clearance rate that limits drug delivery. Also, in some conditions, nanomaterial can disintegrate or aggregate and lose their healing activities and become toxic substances (Singh and Nehru, 2008). Moreover, the chemical synthesis of NPs has some limitations like high costs, energy consumption, and producing poisonous by-products. So, green synthesis of nano-based materials using plants or microorganisms derived compounds as a non-polluting and cost-effective approach has gained popularity.
On the other hand chemical complexity of natural compounds, low yield of their production in crude extract, time of cost consuming process of their extraction, purification and identification, their incompatibility with high-throughput screening, high probability of rediscovery of known compounds; makes the discovery of novel microbial compounds and scales up of their industrial production rather challenging (Lam, 2007). Despite the mentioned constraints, the therapeutic potential of nano and microbial driven compounds is undeniable, and mainly their toxicity concern should be resolved to develop promising safe therapeutic strategies in the future.
Statements
Author contributions
FS collected the data and drafted the manuscript. FM gave the outline and edited the paper.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AhmedR.TariqM.AliI.AsgharR.KhanamP. N.AugustineR.et al (2018). Novel electrospun chitosan/polyvinyl alcohol/zinc oxide nanofibrous mats with antibacterial and antioxidant properties for diabetic wound healing. Int. J. Biol. Macromol.120, 385–393. 10.1016/j.ijbiomac.2018.08.057
2
AkturkO.KismetK.YastiA. C.KuruS.DuymusM. E.KayaF.et al (2016). Collagen/gold nanoparticle nanocomposites: a potential skin wound healing biomaterial. J. Biomater. Appl.31 (2), 283–301. 10.1177/0885328216644536
3
AlipourR.KhorshidiA.ShojaeiA. F.MashayekhiF.MoghaddamM. J. M. (2019). Skin wound healing acceleration by Ag nanoparticles embedded in PVA/PVP/Pectin/Mafenide acetate composite nanofibers. Polym. Test.79, 106022. 10.1016/j.polymertesting.2019.106022
4
AlonsoJ. E.LeeJ.BurgessA. R.BrownerB. D. (1996). The management of complex orthopedic injuries. Surg. Clin.76 (4), 879–903. 10.1016/s0039-6109(05)70486-2
5
AnilkumarT.MuhamedJ.JoseA.JyothiA.MohananP.KrishnanL. K. (2011). Advantages of hyaluronic acid as a component of fibrin sheet for care of acute wound. Biologicals.39 (2), 81–88. 10.1016/j.biologicals.2011.01.003
6
Auf Dem KellerU.KüminA.BraunS.WernerS. (2000). “Reactive oxygen species and their detoxification in healing skin wounds. J. Investig. Dermatol. Symp. Proc.11, 106–111. 10.1038/sj.jidsymp.5650001
7
AugustineR.DominicE. A.RejuI.KaimalB.KalarikkalN.ThomasS. (2014). Electrospun polycaprolactone membranes incorporated with ZnO nanoparticles as skin substitutes with enhanced fibroblast proliferation and wound healing. RSC Adv.4 (47), 24777–24785. 10.1039/C4RA02450H
8
BaoJ.YangB.SunY.ZuY.DengY. (2013). A berberine-loaded electrospun poly-(ε-caprolactone) nanofibrous membrane with hemostatic potential and antimicrobial property for wound dressing. J. Biomed. Nanotechnol.9 (7), 1173–1180. 10.1166/jbn.2013.1629
9
BarathManiKanthS.KalishwaralalK.SriramM.PandianS. R. K.YounH.-s.EomS.et al (2010). Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J. Nanobiotechnol.8 (1), 16. 10.1186/1477-3155-8-16
10
BaruiA. K.VeeriahV.MukherjeeS.MannaJ.PatelA. K.PatraS.et al (2012). Zinc oxide nanoflowers make new blood vessels. Nanoscale.4 (24), 7861–7869. 10.1039/c2nr32369a
11
BhaskerH.UdupaS. L.UdupaA. L. (2004). Effect of nifedipine and amlodipine on wound healing in rats. Indian J. Physicol. Pharmacol.48 (1), 111–114.
12
BigliardiP. L.TobinD. J.Gaveriaux‐RuffC.Bigliardi‐QiM. (2009). Opioids and the skin–where do we stand?. Exp. Dermatol.18 (5), 424–430. 10.1111/j.1600-0625.2009.00844.x
13
BonferoniM.SandriG.DelleraE.RossiS.FerrariF.MoriM.et al (2014). Ionic polymeric micelles based on chitosan and fatty acids and intended for wound healing. Comparison of linoleic and oleic acid. Eur. J. Pharm. Biopharm.87 (1), 101–106. 10.1016/j.ejpb.2013.12.018
14
BrownE. J. (1995). Phagocytosis. Bioessays.17 (2), 109–117. 10.1002/bies.950170206
15
BrownG. L.CurtsingerL. J.WhiteM.MitchellR. O.PietschJ.NordquistR.et al (1988). Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann. Surg.208 (6), 788. 10.1097/00000658-198812000-00019
16
CamposA. C.GrothA. K.BrancoA. B. (2008). Assessment and nutritional aspects of wound healing. Curr. Opin. Clin. Nutr. Metab. Care.11 (3), 281–288. 10.1097/MCO.0b013e3282fbd35a
17
ChakrabortyS. P.SahuS. K.MahapatraS. K.SantraS.BalM.RoyS.et al (2010). Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents. Nanotechnology.21 (10), 105103. 10.1088/0957-4484/21/10/105103
18
ChenX.PengL.-H.ShanY.-H.LiN.WeiW.YuL.et al (2013). Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery. Int. J. Pharm.447 (1-2), 171–181. 10.1016/j.ijpharm.2013.02.054
19
ChhibberS.KaurJ.KaurS. (2018). Liposome entrapment of bacteriophages improves wound healing in a diabetic mouse MRSA infection. Front. Microbiol.9, 561. 10.3389/fmicb.2018.00561
20
ChienL.-J.LeeC.-K. (2007). Hyaluronic acid production by recombinant Lactococcus lactis. Appl. Microbiol. Biotechnol.77 (2), 339–346. 10.1007/s00253-007-1153-z
21
ChigurupatiS.MughalM. R.OkunE.DasS.KumarA.McCafferyM.et al (2013). Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing. Biomaterials.34 (9), 2194–2201. 10.1016/j.biomaterials.2012.11.061
22
ChoiM. J.MaibachH. I. (2003). Role of ceramides in skin stress: ultraviolet light, tape stripping and crowding. Exog. Dermatol.2 (6), 286–294. 10.1159/000081565
23
ChongB. F.BlankL. M.MclaughlinR.NielsenL. K. (2005). Microbial hyaluronic acid production. Appl. Microbiol. Biotechnol.66 (4), 341–351. 10.1007/s00253-004-1774-4
24
ChuY.YuD.WangP.XuJ.LiD.DingM. (2010). Nanotechnology promotes the full‐thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats. Wound Repair and Regeneration.18 (5), 499–505. 10.1111/j.1524-475X.2010.00612.x
25
ClarkR. A. F.HensonP. M. (2013). The molecular and cellular biology of wound repair. Berlin, Germany: Springer Science and Business Media. 10.1007/978-1-4615-1795-5
26
DasS.DowdingJ. M.KlumpK. E.McGinnisJ. F.SelfW.SealS. (2013). Cerium oxide nanoparticles: applications and prospects in nanomedicine. Nanomedicine.8 (9), 1483–1508. 10.2217/nnm.13.133
27
DasS.SinghS.DowdingJ. M.OommenS.KumarA.SayleT. X.et al (2012). The induction of angiogenesis by cerium oxide nanoparticles through the modulation of oxygen in intracellular environments. Biomaterials.33 (31), 7746–7755. 10.1016/j.biomaterials.2012.07.019
28
DavanR.PrasadR.JakkaV. S.AparnaR.PhaniA.JacobB.et al (2012). Cerium oxide nanoparticles promotes wound healing activity in in-vivo animal model. J. Bionanoscience.6 (2), 78–83. 10.1016/j.biomaterials.2012.07.019
29
De JongW. H.BormP. J. (2008). Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed.3 (2), 133. 10.2147/ijn.s596
30
DegreefH. J. (1998). How to heal a wound fast. Dermatol. Clin.16 (2), 365–375. 10.1016/s0733-8635(05)70019-x
31
desJardins-ParkH. E.FosterD. S.LongakerM. T. (2018). Fibroblasts and wound healing: an update. Regen Med.13 (5), 491–495. 10.2217/rme-2018-0073
32
DharmaniP.De SimoneC.ChadeeK. (2013). The probiotic mixture VSL# 3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor. PLoS One.8 (3), e58671. 10.1371/journal.pone.0058671
33
Di MarzioL.CinqueB.De SimoneC.CifoneM. G. (1999). Effect of the lactic acid BacteriumStreptococcus thermophilus on ceramide levels in human KeratinocytesIn vitro and stratum corneum in vivo. J. Invest. Dermatol.113 (1), 98–106. 10.1046/j.1523-1747.1999.00633.x
34
FangQ.YaoZ.FengL.LiuT.WeiS.XuP.et al (2020). Antibiotic-loaded chitosan-gelatin scaffolds for infected seawater immersion wound healing. Int. J. Biol. Macromol.159, 1140-1155. 10.1016/j.ijbiomac.2020.05.126
35
FischerM.GebhardF.HammerT.ZurekC.MeurerG.MarquardtC.et al (2017). Microbial alginate dressings show improved binding capacity for pathophysiological factors in chronic wounds compared to commercial alginate dressings of marine origin. J. Biomater. Appl.31 (9), 1267–1276. 10.1177/0885328217702173
36
FolkmanJ.D’AmoreP. A. (1996). Blood vessel formation: what is its molecular basis?. Cell.87 (7), 1153–1155. 10.1016/s0092-8674(00)81810-3
37
FordjourL.D’souzaA.CaiC.AhmadA.ValenciaG.KumarD.et al (2010). Comparative effects of probiotics, prebiotics, and synbiotics on growth factors in the large bowel in a rat model of formula-induced bowel inflammation. J. Pediatr. Gastroenterol. Nutr.51 (4), 507–513. 10.1097/MPG.0b013e3181df5ff2
38
FriedmanA. J.HanG.NavatiM. S.ChackoM.GuntherL.AlfieriA.et al (2008). Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide.19 (1), 12–20. 10.1016/j.niox.2008.04.003
39
FukuiT.KawaguchiA. T.TakekoshiS.MiyasakaM.TanakaR. (2012). Liposome‐encapsulated hemoglobin accelerates skin wound healing in mice. Artif. Organs.36 (2), 161–169. 10.1111/j.1525-1594.2011.01371.x
40
GaoY.HanY.CuiM.TeyH. L.WangL.XuC. (2017). ZnO nanoparticles as an antimicrobial tissue adhesive for skin wound closure. J. Mater. Chem. B.5 (23), 4535–4541. 10.1039/c7tb00664k
41
GholamiM.MohammadiR.ArzanlouM.DourbashF. A.KouhsariE.MajidiG.et al (2017). In vitro antibacterial activity of poly (amidoamine)-G7 dendrimer. BMC Infectious Diseases.17 (1), 395. 10.1186/s12879-017-2513-7
42
GohM.HwangY.TaeG. (2016). Epidermal growth factor loaded heparin-based hydrogel sheet for skin wound healing. Carbohydr. Polym.147, 251–260. 10.1016/j.carbpol.2016.03.072
43
GonzalezA. C. d. O.CostaT. F.AndradeZ. d. A.MedradoA. R. A. P. (2016). Wound healing-A literature review. An. Bras. Dermatol.91 (5), 614–620. 10.1590/abd1806-4841.20164741
44
GosainA.DiPietroL. A. (2004). Aging and wound healing. World Journal of Surgery.28 (3), 321–326. 10.1007/s00268-003-7397-6
45
GuB. K.ParkS. J.KimM. S.LeeY. J.KimJ.-I.KimC.-H. (2016). Gelatin blending and sonication of chitosan nanofiber mats produce synergistic effects on hemostatic functions. Int. J. Biol. Macromol.82, 89–96. 10.1016/j.ijbiomac.2015.10.009
46
GurtnerG. C.WernerS.BarrandonY.LongakerM. T. (2008). Wound repair and regeneration. Nature.453 (7193), 314–321. 10.1038/nature07039
47
HachichaW.KodjikianL.FessiH. (2006). Preparation of vancomycin microparticles: importance of preparation parameters. Int. J. Pharm.324 (2), 176–184. 10.1016/j.ijpharm.2006.06.005
48
HanG.CeilleyR. (2017). Chronic wound healing: a review of current management and treatments. Adv. Ther.34 (3), 599–610. 10.1007/s12325-017-0478-y
49
HartJ. (2002). Inflammation 1: its role in the healing of acute wounds. J. Wound Care.11 (6), 205–209. 10.12968/jowc.2002.11.6.26411
50
HeldinC.-H.WestermarkB. (1988). “Role of platelet-derived growth factor in vivo,” in The molecular and cellular biology of wound repair. Berlin, Germany: Springer), 249–273. 10.1007/978-1-4899-0185-9_7
51
HuseiniH. F.RahimzadehG.FazeliM. R.MehrazmaM.SalehiM. (2012). Evaluation of wound healing activities of kefir products. Burns.38 (5), 719–723. 10.1016/j.burns.2011.12.005
52
ImA.-R.KimJ. Y.KimH.-S.ChoS.ParkY.KimY. S. (2013). Wound healing and antibacterial activities of chondroitin sulfate-and acharan sulfate-reduced silver nanoparticles. Nanotechnology.24 (39), 395102. 10.1088/0957-4484/24/39/395102
53
Iruela-ArispeM. L.DvorakH. (1997). Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb. Haemostasis.78 (1), 672–677. 10.1055/s-0038-1657610
54
IzawaN.HanamizuT.IizukaR.SoneT.MizukoshiH.KimuraK.et al (2009). Streptococcus thermophilus produces exopolysaccharides including hyaluronic acid. J. Biosci. Bioeng.107 (2), 119–123. 10.1016/j.jbiosc.2008.11.007
55
JanisJ.AttingerC. (2006). The basic science of wound healing. Plast. Reconstr. Surg.117 (7 Suppl. l), 12S–34S. 10.1097/01.prs.0000225430.42531.c2
56
JensenJ. M.FörlM.Winoto‐MorbachS.SeiteS.SchunckM.ProkschE.et al (2005). Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging. Exp. Dermatol.14 (8), 609–618. 10.1111/j.0906-6705.2005.00342.x
57
JiangK.LongY.-Z.ChenZ.-J.LiuS.-L.HuangY.-Y.JiangX.et al (2014). Airflow-directed in situ electrospinning of a medical glue of cyanoacrylate for rapid hemostasis in liver resection. Nanoscale.6 (14), 7792–7798. 10.1039/c4nr01412j
58
JunJ.-I.LauL. F. (2011). Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat. Rev. Drug Discov.10 (12), 945. 10.1038/nrd3599
59
KarczewskiJ.TroostF. J.KoningsI.DekkerJ.KleerebezemM.BrummerR.-J. M.et al (2010). Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol.298 (6), G851–G859. 10.1152/ajpgi.00327.2009
60
KarriV. V. S. R.KuppusamyG.TalluriS. V.MannemalaS. S.KolliparaR.WadhwaniA. D.et al (2016). Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing. Int. J. Biol. Macromol.93, 1519–1529. 10.1016/j.ijbiomac.2016.05.038
61
KaushikM.NiranjanR.ThangamR.MadhanB.PandiyarasanV.RamachandranC.et al (2019). Investigations on the antimicrobial activity and wound healing potential of ZnO nanoparticles. Appl. Surf. Sci.479, 1169–1177. 10.1016/j.apsusc.2019.02.189
62
KhatamiM.VarmaR. S.ZafarniaN.YaghoobiH.SaraniM.KumarV. G. (2018). Applications of green synthesized Ag, ZnO and Ag/ZnO nanoparticles for making clinical antimicrobial wound-healing bandages. Sustainable Chemistry and Pharmacy.10, 9–15. 10.1016/j.scp.2018.08.001
63
KhorasaniM. T.JoorablooA.AdeliH.Mansoori-MoghadamZ.MoghaddamA. (2019). Design and optimization of process parameters of polyvinyl (alcohol)/chitosan/nano zinc oxide hydrogels as wound healing materials. Carbohydr. Polym.207, 542–554. 10.1016/j.carbpol.2018.12.021
64
KimJ. E.LeeJ.JangM.KwakM. H.GoJ.KhoE. K.et al (2015). Accelerated healing of cutaneous wounds using phytochemically stabilized gold nanoparticle deposited hydrocolloid membranes. Biomaterials science.3 (3), 509–519. 10.1039/c4bm00390j
65
KimJ. Y.KimH.JungB. J.KimN.-R.ParkJ. E.ChungD. K. (2013). Lipoteichoic acid isolated from Lactobacillus plantarum suppresses LPS-mediated atherosclerotic plaque inflammation. Mol. Cell.35 (2), 115–124. 10.1007/s10059-013-2190-3
66
KiritsiD.NyströmA. (2018). The role of TGFβ in wound healing pathologies. Mechanisms of ageing and development.172, 51–58. 10.1016/j.mad.2017.11.004
67
KoganG.ŠoltésL.SternR.GemeinerP. (2007). Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol. Lett.29 (1), 17–25. 10.1007/s10529-006-9219-z
68
KomarčevićA. (2000). Modern approach to wound management. Med. Pregl.53 (7–8), 363–368.
69
KoriaP.YagiH.KitagawaY.MegeedZ.NahmiasY.SheridanR.et al (2011). Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds. Proc. Natl. Acad. Sci. Unit. States Am.108 (3), 1034–1039. 10.1073/pnas.1009881108
70
KüchlerS.WolfN. B.HeilmannS.WeindlG.HelfmannJ.YahyaM. M.et al (2010). 3D-wound healing model: influence of morphine and solid lipid nanoparticles. J. Biotechnol.148 (1), 24–30. 10.1016/j.jbiotec.2010.01.001
71
KumarS.LakshmananV.-K.RajM.BiswasR.HiroshiT.NairS. V.et al (2013). Evaluation of wound healing potential of β-chitin hydrogel/nano zinc oxide composite bandage. Pharmaceut. Res.30 (2), 523–537. 10.1007/s11095-012-0898-y
72
KwonM. J.AnS.ChoiS.NamK.JungH. S.YoonC. S.et al (2012). Effective healing of diabetic skin wounds by using nonviral gene therapy based on minicircle vascular endothelial growth factor DNA and a cationic dendrimer. J. Gene Med.14 (4), 272–278. 10.1002/jgm.2618
73
LamK. S. (2007). New aspects of natural products in drug discovery. Trends Microbiol.15 (6), 279–289. 10.1016/j.tim.2007.04.001
74
LauP.BidinN.IslamS.ShukriW. N. B. W. M.ZakariaN.MusaN.et al (2017). Influence of gold nanoparticles on wound healing treatment in rat model: photobiomodulation therapy. Laser Surg. Med.49 (4), 380–386. 10.1002/lsm.22614
75
LawrenceW. T. (1998). Physiology of the acute wound. Clin. Plast. Surg.25 (3), 321–340.
76
LazarusG. S.CooperD. M.KnightonD. R.MargolisD. J.PercoraroR. E.RodeheaverG.et al (1994). Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen.2 (3), 165–170. 10.1046/j.1524-475X.1994.20305.x
77
LeuJ.-G.ChenS.-A.ChenH.-M.WuW.-M.HungC.-F.YaoY.-D.et al (2012). The effects of gold nanoparticles in wound healing with antioxidant epigallocatechin gallate and α-lipoic acid. Nanomed. Nanotechnol. Biol. Med.8 (5), 767–775. 10.1016/j.nano.2011.08.013
78
LewL.-C.GanC.-Y.LiongM.-T. (2013). Dermal bioactives from lactobacilli and bifidobacteria. Ann. Microbiol.63 (3), 1047–1055. 10.1007/s13213-012-0561-1
79
LewL. C.LiongM. T. (2013). Bioactives from probiotics for dermal health: functions and benefits. J. Appl. Microbiol.114 (5), 1241–1253. 10.1111/jam.12137
80
LewL.LiongM. (2012). Divalent ions of Mn and Mg improved sphingomyelinase activity of Lactobacillus rhamnosus FTDC 8313. Biosci. Biotechnol. Biochem.
81
LiJ.ChenJ.KirsnerR. (2007). Pathophysiology of acute wound healing. Clin. Dermatol.25 (1), 9–18. 10.1016/j.clindermatol.2006.09.007
82
LiQ.LuF.ZhouG.YuK.LuB.XiaoY.et al (2017). Silver inlaid with gold nanoparticle/chitosan wound dressing enhances antibacterial activity and porosity, and promotes wound healing. Biomacromolecules.18 (11), 3766–3775. 10.1021/acs.biomac.7b01180
83
LiY.ZhuH.WangS.QianX.FanJ.WangZ.et al (2015). Interplay of oxidative stress and autophagy in PAMAM dendrimers-induced neuronal cell death. Theranostics.5 (12), 1363. 10.7150/thno.13181
84
LiZ.LiuM.WangH.DuS. (2016). Increased cutaneous wound healing effect of biodegradable liposomes containing madecassoside: preparation optimization, in vitro dermal permeation, and in vivo bioevaluation. Int. J. Nanomed.11, 2995. 10.2147/IJN.S105035
85
LiuL.DuG.ChenJ.ZhuY.WangM.SunJ. (2009). Microbial production of low molecular weight hyaluronic acid by adding hydrogen peroxide and ascorbate in batch culture of Streptococcus zooepidemicus. Bioresour. Technol.100 (1), 362–367. 10.1016/j.biortech.2008.05.040
86
LiuX.NielsenL. H.KłodzińskaS. N.NielsenH. M.QuH.ChristensenL. P.et al (2018). Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun fibrous mats for wound healing. Eur. J. Pharm. Biopharm.123, 42–49. 10.1016/j.ejpb.2017.11.004
87
LoombaL.ScarabelliT. (2013). Metallic nanoparticles and their medicinal potential. Part II: aluminosilicates, nanobiomagnets, quantum dots and cochleates. Ther. Deliv.4 (9), 1179–1196. 10.4155/tde.13.74
88
LordM. S.EllisA. L.FarrugiaB. L.WhitelockJ. M.GrenettH.LiC.et al (2017). Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing. J. Contr. Release.250, 48–61. 10.1016/j.jconrel.2017.02.009
89
LuB.LiT.ZhaoH.LiX.GaoC.ZhangS.et al (2012). Graphene-based composite materials beneficial to wound healing. Nanoscale.4 (9), 2978–2982. 10.1039/c2nr11958g
90
LuZ.GaoJ.HeQ.WuJ.LiangD.YangH.et al (2017). Enhanced antibacterial and wound healing activities of microporous chitosan-Ag/ZnO composite dressing. Carbohydr. Polym.156, 460–469. 10.1016/j.carbpol.2016.09.051
91
LukicJ.ChenV.StrahinicI.BegovicJ.Lev‐TovH.DavisS. C.et al (2017). Probiotics or pro‐healers: the role of beneficial bacteria in tissue repair. Wound Repair Regen.25 (6), 912–922. 10.1111/wrr.12607
92
MahmoudA. A.SalamaA. H. (2016). Norfloxacin-loaded collagen/chitosan scaffolds for skin reconstruction: preparation, evaluation and in-vivo wound healing assessment. Eur. J. Pharmaceut. Sci.83, 155–165. 10.1016/j.ejps.2015.12.026
93
MajewskaI.Gendaszewska-DarmachE. (2011). Proangiogenic activity of plant extracts in accelerating wound healing-a new face of old phytomedicines. Acta Biochimica Polonica.58 (4), 449. 10.18388/abp.2011_2210
94
MartinezL. R.HanG.ChackoM.MihuM. R.JacobsonM.GialanellaP.et al (2009). Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J. Invest. Dermatol.129 (10), 2463–2469. 10.1038/jid.2009.95
95
MasoodN.AhmedR.TariqM.AhmedZ.MasoudM. S.AliI.et al (2019). Silver nanoparticle impregnated chitosan-PEG hydrogel enhances wound healing in diabetes induced rabbits. Int. J. Pharm.559, 23–36. 10.1016/j.ijpharm.2019.01.019
96
Meddahi-PelléA.LegrandA.MarcellanA.LouedecL.LetourneurD.LeiblerL. (2014). Organ repair, hemostasis, and in vivo bonding of medical devices by aqueous solutions of nanoparticles. Angew. Chem. Int. Ed.53 (25), 6369–6373. 10.1002/anie.201401043
97
MeszarosA. J.ReichnerJ. S.AlbinaJ. E. (2000). Macrophage-induced neutrophil apoptosis. J. Immunol.165 (1), 435–441. 10.4049/jimmunol.165.1.435
98
MiguelS. P.SequeiraR. S.MoreiraA. F.CabralC. S.MendonçaA. G.FerreiraP.et al (2019). An overview of electrospun membranes loaded with bioactive molecules for improving the wound healing process. Eur. J. Pharm. Biopharm.139, 1–22. 10.1016/j.ejpb.2019.03.010
99
MihaiM. M.DimaM. B.DimaB.HolbanA. M. (2019). Nanomaterials for wound healing and infection control. Materials.12 (13), 2176. 10.3390/ma12132176
100
MihaiM. M.PredaM.LunguI.GestalM. C.PopaM. I.HolbanA. M. (2018). Nanocoatings for chronic wound repair—modulation of microbial colonization and biofilm formation. Int. J. Mol. Sci.19 (4), 1179. 10.3390/ijms19041179
101
MirM.AliM. N.BarakullahA.GulzarA.ArshadM.FatimaS.et al (2018). Synthetic polymeric biomaterials for wound healing: a review. Progress in biomaterials.7 (1), 1–21. 10.1007/s40204-018-0083-4
102
MohammedsaeedW.CruickshankS.McBainA. J.O’NeillC. A. (2015). Lactobacillus rhamnosus GG lysate increases re-epithelialization of keratinocyte scratch assays by promoting migration. Sci. Rep.5, 16147. 10.1038/srep16147
103
MorettiE.MazziL.BonechiC.SalvaticiM. C.IacoponiF.RossiC.et al (2016). Effect of quercetin-loaded liposomes on induced oxidative stress in human spermatozoa. Reprod. Toxicol.60, 140–147. 10.1016/j.reprotox.2016.02.012
104
MorgadoP. I.MiguelS. P.CorreiaI. J.Aguiar-RicardoA. (2017). Ibuprofen loaded PVA/chitosan membranes: a highly efficient strategy towards an improved skin wound healing. Carbohydr. Polym.159, 136–145. 10.1016/j.carbpol.2016.12.029
105
MorifujiM.KitadeM.FukasawaT.YamajiT.IchihashiM. (2017). Exopolysaccharides isolated from milk fermented with lactic acid bacteria prevent ultraviolet-induced skin damage in hairless mice. Int. J. Mol. Sci.18 (1), 146. 10.3390/ijms18010146
106
MosserD. M.EdwardsJ. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol.8 (12), 958. 10.1038/nri2448
107
NamG.RangasamyS.PurushothamanB.SongJ. M. (2015). The application of bactericidal silver nanoparticles in wound treatment. Nanomater. Nanotechnol.5, 5–23. 10.5772/60918
108
NamaziH.RakhshaeiR.HamishehkarH.KafilH. S. (2016). Antibiotic loaded carboxymethylcellulose/MCM-41 nanocomposite hydrogel films as potential wound dressing. Int. J. Biol. Macromol.85, 327–334. 10.1016/j.ijbiomac.2015.12.076
109
NaskarA.KimK.-s. (2020). Recent advances in nanomaterial-based wound-healing therapeutics. Pharmaceutics.12 (6), 499. 10.3390/pharmaceutics12060499
110
NatarajanS.WilliamsonD.StiltzA. J.HardingK. (2000). Advances in wound care and healing technology. Am. J. Clin. Dermatol.1 (5), 269–275. 10.2165/00128071-200001050-00002
111
NethiS. K.DasS.PatraC. R.MukherjeeS. (2019). Recent advances in inorganic nanomaterials for wound-healing applications. Biomaterials science.7 (7), 2652–2674. 10.1039/c9bm00423h
112
PaaverU.TammI.LaidmäeI.LustA.KirsimäeK.VeskiP.et al (2014). Soluplus graft copolymer: potential novel carrier polymer in electrospinning of nanofibrous drug delivery systems for wound therapy. BioMed Res. Int.2014, 789765. 10.1155/2014/789765
113
PeralM.RachidM.GobbatoN.MartinezM. H.ValdezJ. (2010). Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum. Clin. Microbiol. Infect.16 (3), 281–286. 10.1111/j.1469-0691.2009.02793.x
114
PivodováV.FrankováJ.GalandákováA.UlrichováJ. (2015). In vitro AuNPs’ cytotoxicity and their effect on wound healing. Nanobiomedicine.2, 7. 10.5772/61132
115
PlockJ. A.RafatmehrN.SinovcicD.SchniderJ.SakaiH.TsuchidaE.et al (2009). Hemoglobin vesicles improve wound healing and tissue survival in critically ischemic skin in mice. Am. J. Physiol. Heart Circ. Physiol.297 (3), H905–H910. 10.1152/ajpheart.00430.2009
116
PoutahidisT.KearneyS. M.LevkovichT.QiP.VarianB. J.LakritzJ. R.et al (2013). Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One.8 (10), e78898. 10.1371/journal.pone.0078898
117
PrinceT.McBainA. J.O’NeillC. A. (2012). Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus induced cell death by competitive exclusion, Appl. Environ. Microbiol.78 (15), 5119-5126. 10.1128/AEM.00595-12
118
RaguvaranR.ManujaB. K.ChopraM.ThakurR.AnandT.KaliaA.et al (2017). Sodium alginate and gum acacia hydrogels of ZnO nanoparticles show wound healing effect on fibroblast cells. Int. J. Biol. Macromol.96, 185–191. 10.1016/j.ijbiomac.2016.12.009
119
RatherH. A.ThakoreR.SinghR.JhalaD.SinghS.VasitaR. (2018). Antioxidative study of cerium oxide nanoparticle functionalised PCL-Gelatin electrospun fibers for wound healing application. Bioactive materials.3 (2), 201–211. 10.1016/j.bioactmat.2017.09.006
120
RisauW. (1997). Mechanisms of angiogenesis. Nature.386 (6626), 671. 10.1038/386671a0
121
RobsonM. C.SteedD. L.FranzM. G. (2001). Wound healing: biologic features and approaches to maximize healing trajectories. Curr. Probl. Surg.38 (2), 72–140. 10.1067/msg.2001.111167
122
Rodriguez‐MerchanE. (2012). Surgical wound healing in bleeding disorders. Haemophilia.18 (4), 487–490. 10.1111/j.1365-2516.2012.02760.x
123
SalimiF.HamediJ.MotevaseliE.MohammadipanahF. (2019). Coexistence of anticoagulant and anti-vascular calcification activities in Kribbella sp. UTMC 267 metabolites. Iran. J. Pharm. Res.18 (1), 459–468.
124
SalimiF.HamediJ.MotevaseliE.MohammadipanahF. (2018a). Isolation and screening of rare Actinobacteria, a new insight for finding natural products with antivascular calcification activity. J. Appl. Microbiol.124 (1), 254–266. 10.1111/jam.13605
125
SalimiF.Jafari‐NodooshanS.ZohourianN.KolivandS.HamediJ. (2018b). Simultaneous anti‐diabetic and anti‐vascular calcification activity of Nocardia sp. UTMC 751. Lett. Appl. Microbiol.66 (2), 110–117. 10.1111/lam.12833
126
SaporitoF.SandriG.BonferoniM. C.RossiS.BoselliC.CornagliaA. I.et al (2018). Essential oil-loaded lipid nanoparticles for wound healing. Int. J. Nanomed.13, 175. 10.2147/IJN.S152529
127
SchaeferL.AuchtungT. A.HermansK. E.WhiteheadD.BorhanB.BrittonR. A. (2010). The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology.156 (6), 1589–1599. 10.1099/mic.0.035642-0
128
SchauberJ.GalloR. L. (2008). Antimicrobial peptides and the skin immune defense system. J. Allergy Clin. Immunol.122 (2), 261–266. 10.1016/j.jaci.2008.03.027
129
SchleeM.HarderJ.KötenB.StangeE.WehkampJ.FellermannK. (2008). Probiotic lactobacilli and VSL# 3 induce enterocyte β‐defensin 2. Clin. Exp. Immunol.151 (3), 528–535. 10.1111/j.1365-2249.2007.03587.x
130
SeisenbaevaG. A.FromellK.VinogradovV. V.TerekhovA. N.PakhomovA. V.NilssonB.et al (2017). Dispersion of TiO 2 nanoparticles improves burn wound healing and tissue regeneration through specific interaction with blood serum proteins. Sci. Rep.7 (1), 15448. 10.1038/s41598-017-15792-w
131
ShirzadM.HamediJ.MotevaseliE.ModarressiM. H. (2018). Anti-elastase and anti-collagenase potential of Lactobacilli exopolysaccharides on human fibroblast. Artificial cells, nanomedicine, and biotechnology.46 (Suppl. 1), 1051–1061. 10.1080/21691401.2018.1443274
132
SinghO. P.NehruR. (2008). Nanotechnology and cancer treatment. Asian J. Exp. Sci.22 (2), 6. 10.2147/IJN.S33838
133
SinnoH.PrakashS. (2013). Complements and the wound healing cascade: an updated review. Plastic surgery international, 2013, 146764. 10.1155/2013/146764
134
SkoverG. (1991). Cellular and biochemical dynamics of wound repair, wound environment in collagen regeneration. Clin. Podiatr. Med. Surg.8, 723–756.
135
Strecker-McGrawM. K.JonesT. R.BaerD. G. (2007). Soft tissue wounds and principles of healing. Emerg. Med. Clin.25 (1), 1–22. 10.1016/j.emc.2006.12.002
136
SzycherM.LeeS. J. (1992). Modern wound dressings: a systematic approach to wound healing. J. Biomater. Appl.7 (2), 142–213. 10.1177/088532829200700204
137
TanL.HuJ.HuangH.HanJ.HuH. (2015). Study of multi-functional electrospun composite nanofibrous mats for smart wound healing. Int. J. Biol. Macromol.79, 469–476. 10.1016/j.ijbiomac.2015.05.014
138
TaoB.LinC.DengY.YuanZ.ShenX.ChenM.et al (2019). Copper-nanoparticle-embedded hydrogel for killing bacteria and promoting wound healing with photothermal therapy. J. Mater. Chem. B.7 (15), 2534–2548. 10.1039/c8tb03272f
139
ToccoI.ZavanB.BassettoF.VindigniV. (2012). Nanotechnology-based therapies for skin wound regeneration. J. Nanomater.2012, 1687-4110. 10.1155/2012/714134
140
ToyL. (2005). Matrix metalloproteinases: their function in tissue repair. J. Wound Care.14 (1), 20–22. 10.12968/jowc.2005.14.1.26720
141
TrabucchiE.PallottaS.MoriniM.CorsiF.FranceschiniR.CasiraghiA.et al (2002). Low molecular weight hyaluronic acid prevents oxygen free radical damage to granulation tissue during wound healing. Int. J. Tissue React.24 (2), 65–71.
142
TranP. A.ZhangL.WebsterT. J. (2009). Carbon nanofibers and carbon nanotubes in regenerative medicine. Adv. Drug Deliv. Rev.61 (12), 1097–1114. 10.1016/j.addr.2009.07.010
143
TricklerW. J.LantzS. M.SchrandA. M.RobinsonB. L.NewportG. D.SchlagerJ. J.et al (2012). Effects of copper nanoparticles on rat cerebral microvessel endothelial cells. Nanomedicine.7 (6), 835–846. 10.2217/nnm.11.154
144
TsalaD. E.AmadouD.HabtemariamS. (2013). Natural wound healing and bioactive natural products. Phytopharmacology.4 (3), 532–560.
145
TurosE.ShimJ.-Y.WangY.GreenhalghK.ReddyG. S. K.DickeyS.et al (2007). Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. Bioorg. Med. Chem. Lett.17 (1), 53–56. 10.1016/j.bmcl.2006.09.098
146
UrieR.GhoshD.RidhaI.RegeK. (2018). Inorganic nanomaterials for soft tissue repair and regeneration. Annu. Rev. Biomed. Eng.20, 353–374. 10.1146/annurev-bioeng-071516-044457
147
ValdezJ.PeralM.RachidM.SantanaM.PerdigonG. (2005). Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clinical microbiology and infection.11 (6), 472–479. 10.1111/j.1469-0691.2005.01142.x
148
VanwijckR. (2001). Surgical biology of wound healing. Bull. Mem. Acad. R. Med. Belg.156 (3–4), 175–184; discussion 185.
149
ViswanathanK.BabuD. B.JayakumarG.RajG. D. (2017). Anti-microbial and skin wound dressing application of molecular iodine nanoparticles. Mater. Res. Express.4 (10), 104003. 10.1088/2053-1591/aa91e5
150
VossG. T.GularteM. S.VogtA. G.GiongoJ. L.VaucherR. A.EcheniqueJ. V.et al (2018). Polysaccharide-based film loaded with vitamin C and propolis: a promising device to accelerate diabetic wound healing. Int. J. Pharm.552 (1–2), 340–351. 10.1016/j.ijpharm.2018.10.009
151
WangJ.WanR.MoY.LiM.ZhangQ.ChienS. (2010). Intracellular delivery of adenosine triphosphate enhanced healing process in full-thickness skin wounds in diabetic rabbits. Am. J. Surg.199 (6), 823–832. 10.1016/j.amjsurg.2009.05.040
152
WangK.QiZ.PanS.ZhengS.WangH.ChangY.et al (2020). Preparation, characterization and evaluation of a new film based on chitosan, arginine and gold nanoparticle derivatives for wound-healing efficacy. RSC Adv.10 (35), 20886–20899. 10.1039/D0RA03704D
153
WangL.CaoH.LiuL.WangB.WalkerW. A.AcraS. A.et al (2014). Activation of EGF receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. J. Biol. Chem, 289, 20234. 10.1074/jbc.M114.553800
154
WeindlG.SchallerM.Schäfer-KortingM.KortingH. (2004). Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol. Physiol.17 (5), 207–213. 10.1159/000080213
155
WidnerB.BehrR.Von DollenS.TangM.HeuT.SlomaA.et al (2005). Hyaluronic acid production in Bacillus subtilis. Appl. Environ. Microbiol.71 (7), 3747–3752. 10.1128/AEM.71.7.3747-3752.2005
156
WinnickaK.SosnowskaK.WieczorekP.SachaP. T.TryniszewskaE. (2011). Poly (amidoamine) dendrimers increase antifungal activity of clotrimazole. Biol. Pharm. Bull.34 (7), 1129–1133. 10.1248/bpb.34.1129
157
XiaQ.LiuZ.WangC.ZhangZ.XuS.HanC. C. (2015). A biodegradable trilayered barrier membrane composed of sponge and electrospun layers: hemostasis and antiadhesion. Biomacromolecules.16 (9), 3083–3092. 10.1021/acs.biomac.5b01099
158
XiangQ.XiaoJ.ZhangH.ZhangX.LuM.ZhangH.et al (2011). Preparation and characterisation of bFGF-encapsulated liposomes and evaluation of wound-healing activities in the rat. Burns.37 (5), 886–895. 10.1016/j.burns.2011.01.018
159
XuJ.ZgheibC.HodgesM. M.HuJ.El KasmiK. C.DasS. S.et al (2016). Nanoceria-MicroRNA-146a conjugate improves wound healing by reducing reactive oxygen species and regulating macrophage polarization. J. Am. Coll. Surg.223 (4), e157. 10.1016/j.jamcollsurg.2016.08.400
160
YangF.WangA.ZengX.HouC.LiuH.QiaoS. (2015). Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions. BMC Microbiology.15 (1), 32. 10.1186/s12866-015-0372-1
161
YangH.LiuC.YangD.ZhangH.XiZ. (2009). Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol.29 (1), 69–78. 10.1002/jat.1385
162
YuK.LuF.LiQ.ChenH.LuB.LiuJ.et al (2017). In situ assembly of Ag nanoparticles (AgNPs) on porous silkworm cocoon-based wound film: enhanced antimicrobial and wound healing activity. Sci. Rep.7 (1), 1–13. 10.1038/s41598-017-02270-6
163
ZahiriM.KhanmohammadiM.GoodarziA.AbabzadehS.FarahaniM. S.MohandesnezhadS.et al (2020). Encapsulation of curcumin loaded chitosan nanoparticle within poly (ε-caprolactone) and gelatin fiber mat for wound healing and layered dermal reconstitution. Int. J. Biol. Macromol.153, 1241–1250. 10.1016/j.ijbiomac.2019.10.255
164
ZavanB.VindigniV.VezzùK.ZorzatoG.LuniC.AbatangeloG.et al (2009). Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebo-controlled study. J. Mater. Sci. Mater. Med.20 (1), 235–247. 10.1007/s10856-008-3566-3
165
ZhangL.MaY.PanX.ChenS.ZhuangH.WangS. (2018). A composite hydrogel of chitosan/heparin/poly (γ-glutamic acid) loaded with superoxide dismutase for wound healing. Carbohydr. Polym.180, 168–174. 10.1016/j.carbpol.2017.10.036
166
ZhaoC.FuQ.SongW.ZhangD.AhatiJ.PanX.et al (2015). Calcifying cyanobacterium (Nostoc calcicola) reactor as a promising way to remove cadmium from water. Ecol. Eng.81, 107–114. 10.1016/j.ecoleng.2015.04.012
167
ZhouY.ChenR.HeT.XuK.DuD.ZhaoN.et al (2016). Biomedical potential of ultrafine Ag/AgCl nanoparticles coated on graphene with special reference to antimicrobial performances and burn wound healing. ACS Appl. Mater. Interfaces.8 (24), 15067–15075. 10.1021/acsami.6b03021
168
ZhouY.PengZ.SevenE. S.LeblancR. M. (2017). Crossing the blood-brain barrier with nanoparticles. J. Contr. Release.270, 290–303. 10.1016/j.jconrel.2017.12.015
169
ZhouZ.JoslinS.DellingerA.EhrichM.BrooksB.RenQ.et al (2010). A novel class of compounds with cutaneous wound healing properties. J. Biomed. Nanotechnol.6 (5), 605–611. 10.1166/jbn.2010.1157
170
Ziv-PolatO.TopazM.BroshT.MargelS. (2010). Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials.31 (4), 741–747. 10.1016/j.biomaterials.2009.09.093
Summary
Keywords
chronic wounds, skin regeneration, wound healing mechanisms, nanomaterials, microbial metabolites
Citation
Salimi F and Mohammadipanah F (2021) Nanomaterials Versus The Microbial Compounds With Wound Healing Property. Front. Nanotechnol. 2:584489. doi: 10.3389/fnano.2020.584489
Received
21 July 2020
Accepted
14 December 2020
Published
28 January 2021
Volume
2 - 2020
Edited by
Yogendra Kumar Mishra, University of Southern Denmark, Denmark
Reviewed by
Mubarak A Mujawar, Florida International University, United States
Yiqun Zhou, University of Miami, United States
Alina Maria Holban, University of Bucharest, Romania
Updates
Copyright
© 2021 Salimi and Mohammadipanah.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fatemeh Salimi, f.salimi@du.ac.ir; Fatemeh Mohammadipanah, fmohammadipanah@ut.ac.ir
This article was submitted to Biomedical Nanotechnology, a section of the journal Frontiers in Nanotechnology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.